Latest 13F institutional holdings

NYSE
Berkshire Hathaway's latest 13F filing discloses significant holdings in companies like Apple, Bank of America, and Coca-Cola as of March 31, 2025.
NYSE
Alibaba Group Holding Ltd's latest 13F filing reveals its holdings as of March 31, 2025, including significant investments in Weibo Corp, XPeng Inc, and Perfect Corp.
NASDAQ
Hancock Whitney Corp's latest 13F filing reveals its holdings as of March 31, 2025, with a total portfolio value exceeding $3 billion.
NASDAQ
Immersion Corp's latest 13F filing discloses its equity holdings as of March 31, 2025, totaling approximately $162.8 million across eight companies.
NYSE
Royal Bank of Canada filed its Form 13F for Q1 2025, revealing holdings totaling $478.5 billion across 25,563 entries, including significant positions in technology and consumer staples.
BTS
Barclays Bank PLC reports no holdings for the quarter ending March 31, 2025, in its latest 13F filing.
NYSE
Barclays PLC's latest 13F filing reveals a vast portfolio of holdings in equities and options, totaling over $352 billion as of March 31, 2025.
NYSE
Invesco's recent 13F-HR filing discloses changes in their investment portfolio, providing insights into their holdings as of the filing date.
NYSE
First Commonwealth Financial Corp /PA/ reports its holdings for the quarter ended March 31, 2025, revealing a total portfolio value of $424,573,628 across 349 entries.
NYSE
A major investment firm revealed its latest portfolio holdings in a recent 13F filing with the Securities and Exchange Commission.
NYSE
DigitalBridge Group's latest 13F filing reveals a diverse investment portfolio valued at over $1.2 billion as of March 31, 2025.
NYSE
Nomura Holdings Inc's latest 13F filing reveals significant holdings and strategic positions in a diverse range of equities and derivatives as of March 31, 2025.
NASDAQ
Axon Enterprise, Inc. reports holding $174.87 million in Cellebrite DI Ltd. as of March 31, 2025.
NYSE
Voya Financial, Inc. reports no holdings for the quarter ended March 31, 2025, with all holdings reported by other managers.
NASDAQ
StoneX Group Inc.'s latest 13F filing reveals their holdings as of March 31, 2025, totaling $1,579,168,000 across 515 positions.
NASDAQ
Finward Bancorp's latest 13F filing reveals a diverse portfolio with significant holdings in technology, dividend-focused funds, and core index ETFs as of March 31, 2025.
NASDAQ
AlTi Global, Inc. reports its holdings for the quarter ended March 31, 2025, revealing a total portfolio value of approximately $3.81 billion.
NYSE
Janus Henderson Group PLC's latest 13F filing reveals an extensive portfolio of 4,554 holdings valued at over $182 billion as of March 31, 2025.
NYSE
Loews Corp's latest 13F filing discloses its equity holdings as of March 31, 2025, including a substantial position in CNA Financial Corporation.
NYSE
CNA Financial Corp's latest 13F filing discloses $156.6 million in managed assets as of March 31, 2025, with shared investment discretion among Loews Corporation, CNA Financial Corporation, The Continental Corporation and Continental Casualty Company.
NYSE
State Street Corp's latest 13F filing for the quarter ended March 31, 2025, discloses its holdings and investment strategies, revealing a significant portfolio valued at over $2.4 trillion.
NYSE
Cohen & Steers, Inc. reports its holdings for the quarter ended March 31, 2025, revealing a diverse portfolio valued at over $54 billion.
NYSE
Brookfield Corp's latest 13F filing unveils significant holdings across various sectors, with a total portfolio value exceeding $17.5 billion as of March 31, 2025.
OTC.Pink
Fairfax Financial Holdings' latest 13F filing unveils a diverse portfolio with substantial investments in companies like BlackBerry, Cleveland-Cliffs, and Orla Mining as of March 31, 2025.
NYSE
Bank of Hawaii Corp filed a 13F notice indicating no holdings were reported for the quarter ending March 31, 2025, with all holdings reported by other reporting managers.
NYSE
NatWest Group plc's latest 13F filing reveals its holdings as of March 31, 2025, with a total value of $339.2 million.
NYSE
BlackRock's latest 13F filing discloses adjustments to its investment portfolio, including new positions in Bullfrog AI and Titan Pharmaceuticals.
Walgreens Boots Alliance's latest 13F filing reveals substantial holdings in BrightSpring Health Services and Cencora, Inc.
NYSE
Merck & Co.'s latest 13F filing reveals its holdings as of March 31, 2025, totaling over $164 million across various biotech and pharmaceutical companies.
NYSE
Calamos Advisors recently filed its 13F with the SEC, revealing changes in its investment portfolio.